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The  mechanism  responsible  for  the  sticking  of  white  blood  cells  to  blood 
vessel  walls  in  early  inflammation  continues  to  pose  a  challenging  problem 
since this reaction represents the key to an overall understanding of the exuda- 
tire  events  set off by injury. 
In studies reported earlier, interference with the clotting of blood in vivo failed  to 
prevent  the  vigorous sticking  of leucocytes  to  vascular  endothelium  within  rabbit 
ear  chambers damaged  by heat.  As a  specific  example,  maximal  activation  of the 
endogenous fibrinolytic system of rabbits by streptokinase  (SK)  administration  did 
not diminish adherence of circulating white blood cells  to endothelium.  Since lysis of 
fibrin in vitro was brisk,  failure  to modify the sticking reaction could be explained 
only by assuming that destruction of fibrin  on the surfaces of both white cells  and 
endothelium failed to keep pace with newly formed material. In a more direct approach 
to the problem, the behavior of white cells in damaged chambers was followed after 
removal of all chemically detectable fibrinogen from the systemic circulation.  Even 
under these conditions, when fibrinogen levels were too low to measure, brisk leuco- 
cytic sticking still developed after ear chambers had been damaged by heat (1).  From 
these  data  it was concluded that  the  sticking reaction  was not causally related  to 
formation of fibrin. 
Such consistent failure to halt white cell  sticking led to an investigation of specific 
pharmacological substances known to block the clotting of blood in vivo. From pre- 
liminary  observations previously reported,  it was anticipated  that one such agent, 
heparin,  would  materially  impede  the  reaction  (2).  Although many anticoagulants 
were available, heparin  and warfarin sodium were selected because of extensive use 
by others; both were of low toxicity  in the ranges used; and because each could be 
administered parenterally to insure adequate blood levels.  Furthermore, both agents 
were known to prevent not only the local but also the generalized Shwartzman reac- 
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tion; a lesion in which leucocytic sticking figures prominently (3, 4).  This as well as 
other evidence has been regarded as support for the contention that polymerization 
of fibrinogen to fibrinoid is essential for development of the Shwartzman lesion (5). 
Unfortunately, the means by which these agents block fibrinoid formation have not 
been exactly defined, nor has a direct relationship been demonstrated between fibrinoid 
formation and leucocytic sticking. 
In general, the relatively non-specific antiproteolytic properties inherent in heparin 
and warfarin sodium were thought responsible for their anticoagulant effect. Warfarin 
sodium interferes with synthesis of prothrombin by hepatic cells; the resultant defi- 
ciency of this enzyme in turn impairs conversion of fibrinogen to fibrin (6).  On  the 
other hand, heparin is more complex since it acts not only as an antithrombin but 
also is reputed to modify the stability of fibrinogen in vivo (7). With reference to the 
last point, when complex sulfonated polysaccharidal polymers structurally similar to 
heparin were given to animals shortly after endotoxin administration, they not only 
impaired the clotting of blood but at the same time enhanced polymerization of fibrino- 
gen  to either fibrinoid or fibrin in rive  (8).  In a  sinailar fashion, when  heparin was 
administered in vivo after endotoxin, it caused a partial polymerization of fibrinogen 
in vitro when plasma was cooled to 4°C. On warming of such plasma, however, poly- 
merization of fibrinogen not only stopped but was reversed; the material formed in the 
cold was eventually restored to a stable suspensoid state (9). 
Despite  lack of  a  clear  appreciation  of  the  mechanisms  involved  in  their 
action, the influence of heparin and warfarin, both alone and in combination, 
on the leucocytic sticking reaction in rabbit ear chambers injured by heat was 
investigated extensively.  The  following  account  defines  this  experience  and 
describes our inability to demonstrate an inhibitory action by anticoagulants 
on  the  sticking  of  white  cells  to  endothelium  during  acute  inflammation. 
Furthermore, totally unexpected phenomena related to heparin administration 
and the development of platelet and fibrin-like thrombi  were encountered. 
Methods 
White male rabbits weighing 2 to 3 kgof mixed New Zealand-Flemish stock wereobtained 
from Eldridge Rabbitry, St.  Louis.  Animals were used for only one experiment, and aside 
from penicillin and streptomycin, received no injections. Plastic ear chambers of the Sandison 
type but modified as noted previously were employed for microscopic studies (2). Only ear 
chambers  that  contain thin, fully mature connective  tissue  devoid  of active inflammation 
were used for experiments. No ear chambers were employed a second time. Microscopic equip- 
ment was  as recorded  before  (2,  10). 
"Heparin sodium I in 400 mg sterile ampules suitable for intravenous administration was 
used as indicated in the text. Warfarin sodium  ~ (supplied as coumadin sodium) in bulk pow- 
dered form was prepared in concentrations of 30 mg/ml in sterile water for intravenous ad- 
ministration. Varidase, s data pertaining to enzyme content may be found with experiments, 
1 Generously supplied by the Upjohn Company, Kalamazoo, Michigan. 
2 Endo Laboratories, Inc., Richmond  Hill, New York, kindly provided this agent. 
8 Dr.  J.  M.  Ruegsegger,  Ledefle Medical Research  Department,  American  Cyanamid 
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mixed in pyrogen-free 5 per cent dextrose in water (Baxter Laboratories) was administered 
by continuou  s intravenous infusion at a rate of 25 ml per hour by a technique described earlier 
(1).  Preparation  and  administration of  both thromboplastin and  thrombin were as  noted 
before  (1). 
Clotting times were measured by the 3 tube Lee-White method using blood from ear veins 
obtained in syringes rinsed with isotonic saline to minimize air leakage and bubble formation. 
One stage prothrombin times were determined by the method of Quick  (11). Blood for pro- 
thrombin times was drawn from ear veins into syringes containing 0.1 molar sodium oxaiate 
for anticoagulation; 0.1 ml oxaiate was mixed with 0.9 ml blood. Death from blood loss follow- 
ing cardiac puncture occurred so frequently in anticoagulated animals that the approach was 
not used for bleeding. Ample samples of blood were always obtained by venipuncture when 
the ear was prewarmed by a jet of hot air. 
All substances for  intravenous use  were  screened for  content  of  bacterial pyrogens  by 
methods described previously (1). Whenever possible, exceptions are noted in text, pyrogenic 
substances were avoided. All glassware and needles were siliconed with desicote  (Beckman 
Instruments, Inc.) and rendered pyrogen-free by sterilizing in dry heat of 170°C  for 2 hours. 
The method of Sailer and Newhouse was used for chemical measurements of fibrinogen 
levels except that rabbit fibrin was used as the reference standard (12). It was found that firm 
clots could be obtained, even after massive heparinization, by adding only thrombin to samples 
of plasma and it was not necessary to use protamine sulfate.  Crystalfine soy bean trypsin 
inhibitor (Worthington Biochemical Corp.)  solution was prepared,  0.01 gm dissolved in 2.5 
ml buffered isotonic saline, to counteract proteolytic activity in blood samples from anhnals 
receiving varidase; 0.05 ml stock solution was added to 1.0 ml blood. 
Electrophoresis of serum  and plasma samples was performed  on paper with the Spinco 
model RD-2 electrophoresis apparatus at room temperature using a veronal buffer of pH 8.6 
with an ionic strength of 0.075. A few electrophoretic patterns were determined with a veronal 
buffer of pH 8.6 and an ionic strength of 0.1  at 37°C with runs of 16 hours as described by 
Smith and Von Korff  (13). 
Titrations to determine the quantity of protamine sulfate required to counteract in vivo 
heparin were performed by the method of Alien (14).  Protamine sulfate in sterile ampules 
containing 10 mg/ml in sodium chloride solution suitable for intravenous administration was 
obtained  from Eli  Lilly and  Company. 
Antibody against  rabbit  fibrin was  prepared  by immunizing mature Rock  Island hens 
intravenously with a  partially purified preparation of rabbit fibrinogen (fraction I, Lot No. 
6804, Pentex Laboratories). The fibrinogen was clotted, washed first in sterile isotonic saline 
and then in distilled water to remove as much occluded protein as possible. The resultant 
fibrin was fragmented in a Ten Broeck tissue grinder and resuspended in saline at a concen- 
tration of 15.7 mg/ml; merthiolate (thimerosal, Lilly) was added in a  concentration of  1 in 
5,000 as preservative. After immunization was completed, the chickens were bled aseptically 
from wing veins; harvested serum was found to contain precipitating antibody to a number of 
different rabbit serum proteins as demonstrated in Ouchterlony plates. However, by repeated 
absorption with small amounts of rabbit serum, it was possible to remove the bulk of cross- 
reacting precipitins leaving only a small amount of antibody against rabbit gamma globulin 
and a substantial quantity of precipitin for fibrinogen. The use of this material for detecting 
small quantities of fibrinogen in  experimental plasma will be discussed in the appropriate 
sections. 
Camer~a~s and photographic conditions were as described previously  (2,  10).  Still photo- 
graphs were made with Kodak ektachrome color  reversal film,  type F.  Ansco anscochrome 
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RESULTS 
A. Heparin Studies: 
1. Effects of Large Doses of Heparin.--In order to obtain evidence for a  clear 
anticoagulant effect of heparin,  very large amounts  were  employed initially. 
In early experiments, 400 mg heparin sodium given by ear vein over a  period of 
2 to 3 minutes produced a  slight rise in temperature; on the average, less than 
TABLE I 
Effect on Whole  Blood  Clotting Times and on Plasma F  ibrinogen Levels  of 400 M g Heparin 
Administered Intravenously to Rabbits 
Sodium 
Animal 
No. 
M-447 
M-410 
M-478 
M-477 
M-452 
Test 
Clotting time (rain.) 
Fibtinogen (mg %) 
Clotting time (min.) 
Fibrinogen (rag %) 
Clotting time (min.) 
Fibrinogen (mg %) 
Clotting time (min.) 
Fibrinogen (mg %) 
Clotting time (rain.) 
Fibrinogen (rag %) 
Con- 
trol* 
18 
784 
13 
472 
4 
472 
10 
629 
21 
390 
Time venous blood obtained  after heparin 
N.3~.~ 
min. 
749 
IN.C. 
478 
N.C. 
446 
N.C. 
518 
N.C. 
352 
3 hrs.. 6hrs__ 
N.C. [ N.C. 
733  739 
N.C.  I N.C. 
430  446 
443  459 
533  507 
325  331 
9 hrs. 
N.C. 
731 
N.C. 
448 
512 
333 
12 hrs. 
N.C. 
N.C. 
4O5 
N°C, 
538 
509 
N.C. 
349 
24 hrs. 
68 
714 
4 
2 
536 
4.5 
610 
30-60 
378 
* Control obtained approximately 15 minutes before heparin administered. 
:~ N.C., no clot. 
0.5°C  when  tested  in  5  rabbits.  Likewise,  peripheral  leucocytic counts  were 
consistently although only modestly increased several hours after administra- 
tion of heparin but  there was  no preceding leucopenic phase)  Although  this 
was regarded as  evidence that  the heparin was  contaminated  by a  bacterial 
pyrogen, the physiological effects were not considered drastic enough to preclude 
use in ear chamber studies. 
This amount of heparin greatly increased  clotting times during the first  9 hours after 
administration. Furthermore, blood usually did not clot when drawn 12 hours later but after 
24 hours, clotting times became either near normal or, as in 3 of 5 rabbits, shorter than control 
values (Table I). Also note that fibrinogen values were not altered by this amount of heparin. 
4  LeQuire e~ a/. reported similar results after administering smaller amounts of heparin to 
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Electrophoresis of plasma after administration  of heparin revealed a substantial  increase in 
mobility of fibrinogen. Although the nature of this effect of heparin  on fibrinogen was  not 
investigated,  it indicated  a significant chemical as well as electrical change in the molecule 
as a result of the anticoagulant.  Serious hemorrhage from venipuncture  sites and minor abra- 
sions was a constant experimental  hazard and occasionally caused death 12 hours or more 
following heparin aAmlnistration but after acute observations had been concluded. 
As soon as 400 mg of heparin was found to be well tolerated,  it was given to rabbits  with 
fully  mature  ear  chambers.  Although  there  was  no  consistent  influence  on  either 
velocity or volume of ear chamber circulation, occasionally the volume of blood flow decreased 
immediately  after heparin  administration.  This hemodynamic  change sometimes lasted  for 
several hours and seem~l to coindde with the peripheral vasoconstriction that preceded the 
modest fever caused by heparin. Brisk flow of blood returned 2 to 3 hours later after tempera- 
ture elevations either reached a plateau or started to subside. In no instance  was the circula- 
tory disturbance sufficient to prevent microscopic study of ear chambers. Similarly, the num- 
ber  of circulating  leucocytes was not detectably altered  in the uninjured  preparation.  In 
short, heparin failed to modify either the circulatory dynamics or the behavior of intravascular 
formed elements within  uninjured  ear chambers. 
After  injury,  the  administration  of  heparin  was  associated  with  several 
events that were not anticipated.  In keeping with preliminary evidence cited 
previously, it was expected leucocytic sticking might be prevented  (2). How- 
ever, following a  detailed re-examination of white  cell behavior,  it was found 
that heparin did not block adherence of white blood cells to endothelium after 
local heat injury (Figs.  1 and 2). Rarely, intense sticking was ddayed in onset, 
sometimes for 2 or 3 hours.  Such occasional retardation of heavy white blood 
call sticking could best be related  to the reduced volume of peripheral  blood 
flow attending fever evoked by administration of heparin. It should be stressed 
that in most experiments  early leucocytic sticking  developed as in untreated 
animals and in no instance was the reaction prevented (Table II). In any event, 
once sticking was well under way, leucocytic diapedesis was brisk so that after 
24 hours many white cells were found within damaged tissue. 
Another completely unexpected and even more spectacular finding was the 
increased  prominence  of thrombotic  phenomena  within  patent  blood vessels 
adjacent  to injured  tissue  (Table  II). This  was evident  sometimes  within  30 
minutes and always by 1 or 2 hours after trauma and, as must be reemphasized, 
developed only within the immediate area of trauma. In damaged ear chambers 
of untreated  rabbits,  formation  of platelet  thrombi  and  the  proliferation  of 
fibrin  strands  is  not a  prominent  finding but  can be seen  when  searched  for 
diligently  (1,  2).  The  first  detectable  change  in  the  injured  chamber  after 
heparin had been given was an increased adhesiveness  of platelets.  Within  a 
few minutes, platelets began to stick to each other in ever greater numbers and 
propagated  as  elastic,  veil-like  thrombi  from isolated  points  along  the  endo- 
thelium  (Fig. 3)' Eventually,  these clumps of platelets  became so bulky that 
they broke apart to form emboli and were swept away into the venous side of 
the systemic circulation. New thrombi usually formed promptly from the same 540  PATHOGENESIS OF  INFLAMMATION. III 
endothelial locations and  the  process  was  repeated  eventually many  times. 
Concurrently, although blood would not clot spontaneously at the skin surface 
or in vitro, long thin strands of elastic, colorless, clear material, could be seen 
within vascular channels  at the site of platelet thrombus  formation  (Fig. 4). 
Not infrequently these strands,  perhaps a  form of fibrin, became coated with 
platelets and red blood cells but  such  trapping was usually transient.  Leuco- 
TABLE II 
Effect of 400 Mg Heparin Sodium Given Intravenously Immediately before Rabbit Ear Chambers 
Were Injured by Heat 
Microscopic events after injury 
Animal 
No. 
Intensity of leucocytic sticking  Incidence of thrombotic phenomena 
M-20 
M-19 
M-24 
M-32 
M-411 
M-494 
M-500 
M-416 
M-394 
M-401 
Light sticking 6 hrs. after injury 
Heavy sticking 3 hrs. after injury 
Heavy  sticking  20  rain.  after 
injury 
Heavy sticking 3 hrs. after injury 
Moderately heavy sticking 1 hr., 
15 rain. after injury 
Moderately heavy sticking 3 hrs. 
after injury 
Heavy sticking 2 hrs., 30 rain. 
after injury 
Heavy sticking 3 hrs., 30 min. 
after injury 
Moderate sticking 2 hrs., 30 rain. 
after injury 
Heavy sticking 6 hrs. after injury 
Platelet thrombi 1 hr. after injury 
Platelet thrombi 1 hr. after injury 
None seen 
None seen 
Platelet thrombi 1 hr., 15 min. after injury 
Platelet thrombi 4  hrs.,  30  min.  after injury. 
Strands of "fibrin-like" material 6 hrs.  after 
injury 
Numerous  platelet and WBC  thrombi 2 hrs., 
30 min. after injury 
Platelet thrombi 40 rain. after injury. Strands 
of "fibrin-like" material 2 hrs. after injury 
Platelet  thrombi  1 hr.,  30  min.  after injury. 
Strands of "fibrin-like" material 6 hrs. after 
injury 
Strands of "fibrin-like" material with platelet 
thrombi 12 hrs. after injury 
cytes did not  seem  to  stick to  the  strands any  more  so than  other cells and 
incorporation of white blood cells into thrombi was not common. There was no 
correlation between the areas of leucocytic sticking, platelet thrombus propaga- 
tion, and formation of this fibrin-like material since or~e often developed without 
the other3 It was usual, however, for platelet thrombi and fibrin strands to be 
closely associated with circulatory stasis as the inflammatory reaction evolved; 
i.e.,  both  stasis  and  these  phenomena  developed  in  channels  subjected  to 
greatest  damage.  Full fledged  stasis with  interrupted  blood  flow  eventually 
5 White cell sticking, often with a unilateral distribution, is most common in damaged and 
often  prestatic  blood  vessels.  Even so, there  seemed  no common  relation  between  sites of 
adherence for leucocytes and these heparin-associated thrombi. F.  ALLISON  AND  M.  G.  LANCASTER  541 
halted thrombus formation. As a  consequence of this association, occlusion of 
the circulation by thrombosis and by stasis after 24 hours was no more extensive 
than  in  untreated  animals  despite  the  exaggerated  formation  of  fibrin-like 
material associated with the large doses of heparin. Accordingly, extended study 
of lesions within ear chambers of heparinized rabbits did not reveal a significant 
difference from  untreated  animals  in  size of lesions  (Figs.  5  and  6).  As  the 
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illustrations also show, there was no intensification of hemorrhage from these 
static channels despite the vigorous anticoagulation. 
2. Effects of Small Doses of Heparin.-- 
The failure of the 400 mg heparin load to either reduce or prevent leucocytie sticking and 
at the same time, the exaggerated development of thrombotic phenomena as described in the 
preceding section suggested an effect related primarily to dose size. Accordingly, heparin was 
given in amounts comparable to dose ranges employed in human beings for clinical anticoagu- 
lation. As may be seen in Text-fig. 1, 2 hours after heparin was given intravenously to 6 rab- 
bits, clotting times were at least 8 times longer than control values. An anticoagulant effect 
of this order compared favorably with that achieved in human beings and thus seemed satis- 
factory for ear chamber experiments. 542  PATHOGENESIS  OF  INFLAMMATION. Ill 
Heparin in the amount of 3.0 mg/kg did not modify the uninjured ear cham- 
ber with reference to the  volume and velocity of blood flow, vascular fragil- 
ity, and the intravascular behavior of leucocytes and platelets. Furthermore, 
ear chambers damaged by heat behaved essentially as after the larger heparin 
load  with  but  one exception. The formation of platelet thrombi and strands 
of fibrin-like material was  only slightly  accentuated even though the  small 
heparin dose was repeated several times at  short  intervals.  Leucocytic  stick- 
ing progressed without  alteration  and  was eventually associated  with  brisk 
diapedesis of white cells.  Furthermore, after 24 hours, there was no evidence 
that the inflammatory reaction was modified by a smaller amount of heparin. 
As  with  larger  heparin  doses,  perivascular  hemorrhage  was not aggravated 
(Figs. 5 and 6). 
Trial of  other  amounts of heparin was  not attempted since there  was  no 
reason to  suspect a  distinct difference from results obtained with the  2  dose 
ranges investigated. 
3. Heparin and Protamine Sulfate Studies.- 
In view of the curious platelet  and "fibrin-like" thrombi that appeared in heat-damaged 
ear chambers of rabbits given a single intravenous load of 400 mg hepaxin, it was of interest 
to determine the influence of a potent heparin antagonist on the system. Protamine sulfate 
was selected because of known efficacy in neutralizing heparin anticoagulant  activity both 
in vivo and in vitro and because of the wide safety margin attending its administration. Study 
of the substance revealed that it did not cause fever, lencopenia, or leucocytosis. Protamine, 
however, did possess the disadvantage that administration of an excess also produced anti- 
coagulation. Thus, it was necessary to determine the optimal dosage required to accomplish 
neutralization of heparin in vivo prior to performance of experiments. 
Initially, protamine  titrations were performed on several rabbits approximately  2 to  3 
hours after 400 mg heparin had been administered by vein since thrombotic phenomena after 
burn injury were most brisk at this time. Under these conditions it was found that approxi- 
mately 0.1 mg protamine sulfate neutralized heparin activity in 1.0 ml of blood. From this 
figure, heparin levels not only of the blood sample but of the entire animal could be estimated 
for performance of ear chamber experiments. 
Mter rabbits were given 400 mg heparin intravenously,  ear chambers were damaged by 
heat; it was then possible to determine when leucocytic sticking and thrombotic phenomena 
reached peak levels. Just at that time, usually 2 to 3 hours after injury (Table III), a sample 
of venous blood was obtained for measuring the clotting time and protamine titration. Im- 
mediately thereafter, an amount of protamine sulfate was given believed sufficient to restore 
clotting times to near control values. The adequacy of the estimated protamine dosage for 
counteracting heparin anticoagulation was checked by two means. First, the heparin content 
of blood obtained just before administration of protamine was measured by a protamine titra- 
tion and from this figure the required dose could be calculated retrospectively. As may be 
seen in Table III, the amount of protamine administered corresponded well with that required 
to neutralize heparin anticoagulation in vitro. Secondly, approximately 2 hours after protamine 
had been given, another specimen of venous blood was obtained for a clotting time determina- 
tion. From Table III, it may be seen that the anticoagulant activity of heparin in this sample 
was not nullified consistently by the administered protamine since moderate clotting time 
prolongation often p~rsisted. This was so even though an excess of protamine, according to the F.  ALLISON  AND  M.  G.  LANCASTER  543 
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titration data, was given in later studies. Since an excess of either material may cause anti- 
coagulation, it was not possible to differentiate their separate effects either in vitro or in vivo. 
The inconclusive nature of the studies with heparin and protamine in vitro 
was also encountered in ear chamber experiments. In this instance, leucocytic 
sticking induced by heat injury in heparinized animals was not modified after 
a  neutralizing dose of protamine had been given (Table III). Likewise, throm- 
botic  phenomena  present  at  the  time  of protamine  administration persisted 
without apparent change.  This was so regardless of the amount  of protamine 
given. Finally, protracted study of ear chambers of rabbits so treated did not 
indicate that the inflammatory reaction differed appreciably from that of either 
untreated or heparinized animals. 
4. The Relation of Time after  Trauma to Thrombus Formation Associated with 
Heparin .- 
As noted previousiy, heparin-associated  platelet thrombi and streamers of fibrin developed 
only in vessels bordering damaged tissue.  Furthermore, since these aggregations  were not 
detected until 30 minutes or longer after injury and heparinization, it suggested either forma- 
tion or release of tissue factors active in triggering the reaction. In order to test this possibility, 
heparin was administered at different times after ear chambers had been damaged by heat. 
Thus, when 400 mg heparin was given 2 hours after injury, a time of brisk leucocytic sticking 
but of little thrombotic activity in untreated rabbits, platelet sticking developed promptly, 
usually within 5 minutes.  Mter 10 minutes,  streamers of fibrin and large platelet thrombi 
were prominent but as noted previously, leucocytic sticking was not altered. 
In a small number of experiments,  400 mg heparin was given either 6 or 24 hours  after 
injury. Even though modest leucocytic sticking persisted at these times, thrombotic phenom- 
ena were not notably enhanced. It should be noted also that the reaction to injury has already 
begun to abate to some extent after the 6th hour in this preparation. As a result, even though 
the results suggested transient release of an active factor or trigger for thrombus formation, 
the brevity of the inflammatory reaction produced in this model may have artificially termi- 
nated  clotting  activity. 
5.  E~ect  of  Defibrinogenation  upon  Heparin  Activity  within  Injured  Ear 
Chambers.- 
From  data  described  in  preceding  sections,  it  was  suspected  that  a  third 
factor, apparently arising from injured tissue, was needed to catalyze the intra- 
vascular  reaction  between  heparin  and  fibrinogen  that  lead  to  accentuated 
thrombotic phenomena. To test this possibility it seemed worthwhile to attempt 
a  blockage of the heparin effect by removing fibrinogen from the circulation of 
rabbits before ear chambers were injured. At the same time, such experimental 
conditions would provide a  check on previous observations wherein leucocytic 
adherence was not substantially altered by either heparinization or defibrino- 
genation  alone. 
Defibrinogenation  of animals was initially attempted by a technique previously described 
(1) except that in these experiments, a purified form of streptokinase (SK), 100,000 units per F.  ALLISON  AND  M.  G.  LANCASTER  545 
vial, was used. The procedure was designed so as to gradually remove all chemically detectable 
fibrinogen from the circulation during an 8 hour infusion yet preserve the peripheral circula- 
tion in a condition suitable for ear chamber studies. As noted before, administration of throm- 
boplastin (TP) followed by thrombin produced many intravascular platelet emboli and stream- 
ers of fibrin that were visible until fibrinogen values became extremely low (1). Although as 
much as a 90 per cent or more reduction in fibrinogen values was universally accomplished, 
it  was not always possible to remove completely all such material.  It was found that  the 
addition of thrombin to plasma obtained from animals after extended defibrinogenation pro- 
duced a small amount  of granular  precipitate  after  the mixtures  were allowed to stand at 
room temperature for 8 to 24 hours. Such prolonged incubation of thrombin with experimental 
plasma was not done in previous studies (1). Although a fibrin web did not form, this granular 
material suggested a clottable protein, perhaps an altered form of the fibrinogen-fibrin complex. 
With  these  results  in  mind,  experiments  were  performed  to  effect  in  rivo 
defibrinogenation  in  5  different  ear  chamber preparations.  The  results  were 
not conclusive since small amounts of clottable protein  were found in plasma 
samples from 4 of the 5 animals despite 10 to 12 hours of infusion. After injury, 
heavy leucocytic sticking appeared in all 5 animals.  Heparin was not given to 
one of these animals because thrombotic phenomena persisted after heat injury; 
subsequently,  no  fibrinogen  was  found  in  the  plasma.  Heparin  was  given  to 
the other 4 animals and in 2 of these there seemed an appreciable delay in the 
appearance  of platelet-fibrin  clots;  whereas,  thrombi  developed  promptly  in 
the remaining 2 animals.  These results could not be interpreted. 
As  a  further  check  on  the  nature  of  this  clottable  protein,  experimental 
plasmas  were assayed for precipitatable  fibrinogen  by using anti-rabbit  fibrin 
chicken (ARFC)  serum  in Ouchterlony double diffusion plates.  A  distinct line 
of precipitate  in agar formed between normal rabbit plasma and the antibody 
(ARFC); whereas, normal rabbit serum did not react in this manner  (Text-fig. 
2).  The specificity of the reaction was verified with purified rabbit fibrinogen. 
As also shown in Text-fig. 2, a distinct line of precipitate formed between ARFC 
serum and plasma from "defibrinogenated" rabbits.  Since this band of precipi- 
tate  connected with  the band obtained from normal plasma,  it indicated  that 
a  substance  immunologically similar  to fibrinogen persisted  in  the  circulation 
of  treated  animals.  Somewhat  confusing,  however,  was  the  fact  that  after 
normal rabbit fibrin was lysed in vilro by added SK, the same line of precipitate 
was found (Text-fig. 3).  This suggested that depolymerization of rabbit fibrin 
by fibrinolysin  (plasmin)  yielded polypeptide fragments that still reacted with 
the  ARFC serum.  Thus,  it  was possible  that  the  precipitate  formed between 
experimental  plasma  and  ARFC serum  (Text-fig. 3)  represented  combination 
of  chicken  precipitin  with  polypeptide  fragments  of rabbit  fibrinogen  rather 
than unclotted  traces of unaltered  fibrinogen alone.  Such a  possibility did not 
seem  too  unlikely  when  it  was  found  that  disruption  of  fibrin  by  another 
proteolytic enzyme such as trypsin  resulted  in a  polypeptide residue  that did 
not react with the  ARFC serum (Text-fig. 3). Unfortunately, trypsin could not 546  PATHOGENESIS  OI~  INFLAMMATION.  III 
be used in vivo in these  experiments since it produced death from acute heart 
failure. 
From  this  information it  was  determined that  5.0  ml  unabsorbed ARFC 
serum could be given intravenously after  10  hours of defibrinogenation with 
TE':T-FIG.  2  TExT-FIG. 3 
TEXT-FIG.  2. Ouchterlony double diffusion  plate. Absorbed anti-rabbit-fibrin chicken serum 
(ACS)  in central well. The contents of the surrounding wells were as follows: (1)  Control 
plasma from rabbit M-623. (2) Plasma from rabbit M-623 after 10 hours of defibrinogenation. 
(3)  Plasma from rabbit M-623 after  11 hours of defibrinogenation and 10.0 ml unabsorbed 
ARFC serum. No clottable protein present. (4) Same as well (3) but 15 minutes after 400 mg 
heparin given. (5) Plasma from rabbit M-623 11 ~  hours after infusion stopped. (6) Serum from 
rabbit M-623. Note total lack of precipitate. 
TEXT-FIG. 3. Ouchterlony double diffusion plate.  As in Text-fig. 2, absorbed anti-rabbit- 
fibrin chicken serum (ACS) in central well. The surrounding wells contained the following: 
(1) Normal oxalated rabbit plasma. (2) Plasma from rabbit M-623 after 11 hours of defibrino 
genation and 10.0 ml unabsorbed ARFC. No clottable protein was found. (3) Normal oxalated 
rabbit plasma clotted with thrombin and digested with trypsin.  (4) Normal oxalated rabbit 
plasma clotted with thrombin and lysed with streptoklnase. (5) Same as well (2). (6) Normal 
rabbit  serum. 
TP-thrombin-SK without disrupting circulatory integrity although the volume 
of blood flow was often temporarily reduced.  Testing of rabbit plasma obtained 
20 minutes after administration of chicken antiserum still revealed a precipitate 
in Ouchterlony plates but no clottable protein was detected even after extended 
incubation. Accordingly, the procedure for defibrinogenation was modified to 
include administration of chicken antiserum after 10 hours of infusion. 
After  ARFC  serum administration, prominent platelet  white  cell  thrombi 
and strands of fibrin-like material became scarce  in 2 of 3  animals; possibly 
because leucocytes and thrombocytes were decreased in number. Ear chambers ]~.  ALLISON  AND  ~[.  G.  LANCASTER  547 
were damaged by heat immediately after the first 5.0 ml of ARFC serum was 
given. Within 5 to 15 minutes, leucocytic sticking appeared along patent chan- 
nels next to the damaged tissue. A second 5.0 ml of chicken serum was given 
about 30 minutes after injury, but it did not alter the sticking reaction. There 
was less evidence of effect on circulatory dynamics. As these observations were 
made, no platelet or fibrin thrombi were seen despite moderate numbers of free 
floating platelets. Blood obtained at this time revealed no fibrinogen by chemical 
means but a precipitate in agar identical with that seen in Text-fig. 2 was still 
obtained with specific antibody (ARFC). 
At this point, after 10 plus hours of defibrinogenation and  10.0  ml anti- 
rabbit-fibrin chicken serum, 400 rag. heparin was given v/a the opposite ear. 
Within a span of 15 to 25 minutes, platelet-fibrin thrombi began to be seen in 
patent vessels nearest the damaged tissue. Venous blood obtained at this time, 
even  though  the  infusion  of  thrombin-SK  continued,  revealed  chemically 
detectable yet quite small amounts of fibrinogen. Within 1 hour after adminis- 
tration of heparin, the circulatory volume of the ear chamber increased and 
inflammation evolved much as  in  untreated  animals.  Throughout all  these 
extraordinary maneuvers, leucocytic sticking progressed although sometimes 
not as vigorously as in untreated rabbits; the reduction usually appeared related 
to  either  peripheral  leucopenia  or  diminished ear  chamber  circulation and 
sometimes a  combination of both. Furthermore, lesions in animals so treated 
revealed considerable infiltration of leucocytes but perivascular hemorrhage 
was less than expected. A profound fall in hematocrit values from venepunctures 
and from perhaps unseen sites of hemorrhage attested the rigor of these experi- 
ments and undoubtedly lowered peripheral blood pressures to account at least 
in part for the modest hemorrhage noted about static ear chamber vessels. 
To sum up, although there was no evidence of platelet or fibrin thrombi 
within injured ear chamber blood vessels immediately after 400  mg heparin 
was given to rabbits cleared of fibrinogen, thrombi began to reappear within 15 
or more minutes. Formation of thrombi correlated well with the reappearance 
of chemically measurable fibrinogen in the circulation. Of especial note, leu- 
cocytic sticking persisted throughout despite maximum defibrinogenation and 
added anticoagulant activity of heparin. From these findings, it seemed that 
the  sticking reaction of leucocytes was clearly separated  from the effect of 
heparin on fibrinogen and platelets. Unfortunately, there was considerable over- 
lap in the times when thrombi appeared. It was thus not possible to state cate- 
gorically that "defibrinogenated" animals had no heparin-associated thrombi. 
Nevertheless, there was the distinct impression that this was so. 
B. Sodium  Warfarin Studies: 
The intravenous administration to rabbits of 15 mg/kg sodium warfarin (coumadin) daily 
for 4 days, according to the schedule of Shapiro and McKay to prevent the generalized 
Shwartzman reaction (4), did not consistently  prolong  prothrombin  times over control values. 548  PATHOGENESIS  OF  INFLAlVIMATION.  III 
Failure to confirm Shapiro's results may have resulted from our use of larger and older rabbits. 
At any rate, as seen in Table IV, administration of 50 mg/kg coumadin daily intravenously 
for 4 or 5 days did increase prothrombin times consistently by at least a factor of 3 over pre- 
treatment levels. Such prolongation was thought  adequate  for experimental purposes since 
it not only exceeded by several times the drug effect usually sought in clinical usage but also 
caused the animals to bleed easily. An appreciable decrease in hematocrit  value was found 
in a few of these animals but there was no obvious blood loss (Table IV). Since coumadin was 
given at least 3 or 4 hours before ear chamber studies were begun, no estimation of pyrogenic- 
ity or of peripheral leucocytes was made although every precaution was  taken  to  prevent 
bacterial contamination and only sterile solutions were used. 
TABLE  IV 
Effect of Sodium Warfarin, 150 Mg Daily, on the Reaction Produced by Heat Trauma 
in Rabbit  Ear Chambers 
Animal 
No. 
M-451 
M-440 
M-457 
M-458 
M-472 
Neight 
kg 
2.6 
3.3 
2.6 
2.6 
2.4 
Total Na 
warfarin 
dosage 
mg 
6OO 
6OO 
6OO 
6OO 
6OO 
Prothrombin 
time 
~efore  After 
lerapy_ 
sec.  sec. 
13.0  49.2 
15.7  61.8 
13.7  57.4 
11.8  53.0 
11.6  52.0 
Hematocrit 
value 
Before  After 
herapy  therapy 
~er cent  per  cent 
37.5 
39.0 
39.0 
Microscopic  events after injury 
Throm- 
botic 
phe- 
nomena 
None 
None 
Intensity of leucocytic 
sticking 
Heavy sticking  1 hr.,  30 
min. after injury 
Light  sticking  1  hr.,  30 
min. 
36.0  None  Heavy 
after 
39.0  None  Heavy 
after 
37.5  None  Light 
after 
after injury 
sticking  4  hrs. 
injury 
sticking  2  hrs. 
injury 
sticking  20  rain. 
injury 
Coumadin treatment did not alter the circulatory dynamics within uninjured 
ear  chambers.  Similarly, leucocytes and platelets were neither increased nor 
decreased in number and there was no suggestion that coumadin changed their 
stickiness. The 4  days of coumadin anticoagulation did not increase vascular 
fragility sufficiently to cause spontaneous leakage of red cells from mature ear 
chamber  blood vessels. 
The inflammatory response elicited by heat injury in ear chambers of rabbits 
fully anticoagulated with coumadin was quite similar in most respects to the 
reaction noted after heparin treatment. Leucocytic sticking was not influenced 
by coumadin pretreatment since margination developed within 15 to 30 minutes 
after  injury and became quite heavy within 2  to  3  hours  (Table IV).  After 
sticking became established, diapedesis of white cells was not delayed or other- 
wise impaired so that there was considerable infiltration  of tissue after 24 hours. :F. ALLISON  AND  M.  G.  LANCASTER  549 
Stasis of blood flow eventuating in perivascular hemorrhage was identical with 
that  of  the  untreated  controls.  Likewise,  coumadin  treatment  did  not  alter 
the time and intensity of appearance of plasma globules. 
By  contrast,  however,  there  was  no  evidence  that  coumadin  augmented 
formation  of  either  platelet  thrombi  or  strands  of  fibrin-like  material  en- 
countered after injury in rabbits given heparin  (Table IV). Actually, throm- 
botic  phenomena  in  rabbits given  coumadin  were  of  the  same  low  order of 
frequency as in untreated controls. 
TABLE V 
Effect of Combining Sodium Warfarin, 150 Mg Daily with 400 Mg Heparin Sodium Given 
Intravenously Immediately before Rabbit Ear Chambers Were Damaged by Heat 
Animal 
No. 
M-466 
M-424 
M-472 
M-492 
M-496 
Total 
Na 
warfarin 
dosage 
kg  mg 
2. ¢  600 
3.(  750 
3.(  750 
3.(  600 
2.4  750 
)rothr, ,mbin I 
ti~ ~Mter 
Be- 
fore  ther- 
ther-  apy  apy ! 
$cc.  $e~. 
17.7  64.0 
14.4  75.0 
13.3  47.6 
14.2  95.0 
15.3  44.6 
Hemal 
val 
Be- 
fore 
ther- 
apy 
per 
cent 
35.0 [ 
42.5 
45.0 
34.5 
36.5 
7it I 
After 
ther- 
apy I 
per 
cenl 
33.0 
33.5 
35.0 
31.0 
41.0 
Microscopic events after injury 
Intensity of leucocytic 
sticking 
Heavy sticking 1 hr., 30 
rain. after injury 
Heavy sticking 1 hr., 15 
min. after injury 
Heavy sticking 1 hr., 15 
min. after injury 
Moderately heavy stick- 
ing 3 hrs. after injury 
Heavy  sticking  2  hrs. 
after injury 
Incidence of thrombotic 
phenomena 
Platelet  thrombi  and  strands  of 
"fibrin-like'  material 50 rain. after 
injury 
Platelet  thrombi  and  strands  of 
"fibrin-like"  material  30  rain. 
after  injury 
Platelet thrombi 1 hr., 15 rain. after 
injury 
No "fibrin-like" material noted 
Platelet  thrombl  noted  but  little 
"fibrin-like" material 2 hrs. after 
injury 
Platelet thromb130 rain. after injury 
No "fibrln-llke" material noted 
C. Combined Anticoagulant Studies: 
Animals in this series of experiments were given heparin sodium and sodium warfarin at 
the same time to determine if their combined anticoagulant action would modify leucocytic 
behavior since neither alone prevented the sticking reaction.  Coumadin, 50 mg/kg, was given 
by vein daily for 4 or 5 days to insure satisfactory prothrombin time prolongation.  On the 
day of study, 400 mg heparin was administered intravenously immediately before ear cham- 
bers were damaged by heat. This combination of agents did not modify either circulatory 
dynamics or behavior of formed elements within uninjured ear chambers. Furthermore, there 
was no evidence that this regimen caused intralumenal formation of fibrin or that it increased 
the vascular fragility of uninjured chambers. 
Following trauma  by heat  to ear chambers of rabbits receiving both anti- 
coagulants,  leucocytic  sticking  developed  within  15  minutes  and  reached 
striking proportions during the next  hour  or so  (Table V).  Sticking of other 550  PATttOGENESIS  OF  INFLAMMATION.  III 
formed elements, however, was much as noted in animals treated with heparin 
alone; i.e.,  platelet-white cell thrombi were prominent. Likewise, the strands 
of fibrin-like material encountered with heparin alone were also noted within 
heavily damaged vascular channels prior to their blockage by stasis. 
Diapedesis of leucocytes was not reduced by these agents as lesions 24 hours 
old revealed a moderate infiltration of cells. Interestingly, there was no accen- 
tuation of hemorrhage about such lesions and plasma globules appeared despite 
combined  anticoagulation.  In  short,  the  simultaneous  use  of  heparin  and 
coumadin with resultant extreme anticoagulation did not modify evolution of 
microscopic burns during the first 24 hours after their inception. 
DISCUSSION 
The exact means by which heparin sodium and sodium warfarin antagonize 
the clotting of blood in vivo has yet to be fully revealed. It is unlikely that either 
substance  completely blocks  the  enzymatic polymerization of fibrinogen to 
fibrin even though high drug levels and gross interference with blood clotting 
can be achieved. Even so,  in the face of the intense pharmacological effect 
achieved with these substances in our experiments, it seems improbable that 
fibrin formation figured significantly in the sticking of leucocytes induced by 
heat injury. The validity of this conclusion was enhanced considerably when it 
was found that white blood cell sticking developed even after maximum doses 
of heparin sodium and sodium warfarin were used simultaneously. These results 
are in agreement with previous data from which it was concluded that fibrin 
formation on the surface of cells was not responsible for the sticking reaction 
(i). 
At first glance, these heparin-associated thrombi did not seem compatible 
with the high level of anticoagulation produced by the drug. It is worth recalling 
that under somewhat different circumstances the undamaged cheek pouch of 
hamsters previously anticoagulated with heparin showed both leucocytic stick- 
ing and formation of white thrombi after several hours of study (16).  It must 
not be forgotten that the preparation of the hamster cheek pouch is an acute 
technique,  always subject  to  variable  but usually slight injury when being 
prepared for study. This is an important consideration since in our ear chamber 
experiments trauma, even though ever so slight, was essential for development 
of thrombi after heparin administration. No thrombi were ever recorded either 
within undamaged rabbit ear chambers or within vessels located peripherally 
some distance in the chamber from the zone of injury. Contrary to the experi- 
ence of Copley who studied other vascular models (17), we did not find increased 
intravascular platelet adhesiveness or clumping in the mature vasculature of 
uninjured ear chambers following either large or small amounts of intravenous 
heparin. It is possible that these contradictions arise from the fact that rabbit 
platelets may be either more resistant to heparin as suggested by Best (18); or, ]~.  ALLISON  AND  M.  G.  LANCASTER  551 
as now seems more likely, the studies of others may have always involved either 
abnormal surfaces or injured blood vessels. 
Even though an experimental explanation for the thrombi was not available, 
it is likely that the fibrin-like substance represented the heparin-precipitatable 
fibrinogen described by Thomas et al. (9). These experiments are the first docu- 
mentation of its occurrence in vivo. 
If, as seems inescapable, these heparin-associated thrombi were related to 
fibrinogen, then their presence contradicted the conclusion that anticoagulants 
eliminated the possibility that fibrinogen is an important factor in the leuco- 
cytic sticking reaction. Fortunately, the studies with defibrinogenated animals 
seemed to clearly separate leucocytic sticking from heparin-associated-thrombi 
since vigorous sticking of white blood cells continued when no thrombi could 
be found. As the last series of experiments indicated, the sticking of white cells 
proceeded when clottable protein could not be detected. Yet, plasma from such 
defibrinogenated animals formed a  precipitate in Ouchterlony plates when set 
up against antibody to rabbit fibrin (Text-fig. 2). Unfortunately, this reaction 
was not specific  enough to differentiate between intact fibrinogen-fibrin mole- 
cules and the polypeptide residue of these substances after depolymerization by 
plasmin (Text-fig. 3). We are thus still left with the possibility that a monolayer 
of fibrinogen molecules could account for the sticking reaction. 
Finally, it has been difficult to reconcile our finding of enhanced thrombus 
formation associated with heparin to the established fact that anticoagulants 
inhibit the Shwartzman reaction, a  lesion wherein both platelet aggregation 
and fibrin formation are prominent. Extended study of heparinized, damaged 
ear chambers for 24 hours or more, however, indicated that the final extent of 
thrombus formation and vascular obstruction was neither more nor less than 
that found in untreated animals. This fact may indicate that the clots were 
physiologically ineffective and did not permanently occlude the circulation. 
On  the  other  hand,  a  more  plausible  possibility is  that  heparin-associated- 
thrombi proliferated only in vessels intensely damaged and therefore most likely 
to undergo occlusion by stasis. Thus, under such special circumstances the clot 
did not increase likelihood of obstruction since the vessels were already destined 
to  become  static.  As  described before,  neither  the  extent nor rate of stasis 
evolution was altered by anticoagulants. If this explanation is then valid, our 
observations are not actually in discord with those of others concerning anti- 
coagulants and the Shwartzman reaction. 
SUtC~RY 
Vigorous anticoagulation with heparin sodium and sodium warfarin singly 
and in combination did not prevent the margination and endothelial sticking 
reaction of leucocytes in rabbit ear chambers damaged by heat. The general 
inflammatory reaction observed in this preparation was similarly uninfluenced 552  PATHOGENESIS  OF  INFLAMMATION.  III 
by the anticoagulants.  An unexpected finding after administration of heparin 
was the enhanced formation of platelet and fibrin-like thrombi within damaged 
ear chambers. Sodium warfarin did not induce or prevent this heparin effect. 
Production  of  these  heparin-associated  thrombi  was  minimized  in  animals 
subjected  to  defibrinogenation  in  vivo  whereas  leucocytic  sticking  was  not 
modified.  Although  defibrinogenation  was  not  absolute,  these  experiments 
represent  additional  proof that  the  sticking  of white  blood cells  to vascular 
endothelium is not causally related to the fibrinogen-fibrin system. 
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EXPLANATION OF PLATE  50 
Pictures were printed as kodachromes from ektachrome positive transparencies by 
Eastman  Kodak Company. Fig. 3 was taken from 16 ram. motion picture film. 
FIG. 1. Leucocytic sticking (L) within venule of ear chamber damaged 2 hours pre- 
viously by heat. Animal untreated.  ×  54. 
FIG. 2.  Leucocytic sticking  (L)  in  venule  1 hour  15  minutes  after ear chamber 
damaged by heat. 400 mg heparin given intravenously prior to injury.  X  54. 
FIG. 3.  Platelet (P)  thrombus  within venule of damaged ear chamber of  rabbit 
given 400 mg heparin intravenously. Note single white blood cell (L) attached to tail 
of  clot.  X  108. 
FIG. 4.  Strand  of fibrin-like (F)  material in  heat-damaged ear chamber  despite 
preceding administration of heparin. India ink (pelikan) given to serve as a marker. 
Note static venule (S) close by.  X  54. 
FIG. 5. Appearance of burn lesion in ear chamber of untreated rabbit 24 hours after 
injury.  X  26. 
FIG. 6. Heat damaged ear chamber of rabbit given 400 mg heparin after 19 hours 
of study. Note, despite large size of lesion, lack of accentuated hemorrhage~.  X  26. TttE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 114  PLATE 50 
(Allison and Lancaster: Pathogenesis of inflammation. III) 